Audio Journal of Cardiovascular Medicine: “COURAGE” Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?

Audio Journal of Cardiovascular Medicine: “COURAGE” Trial Assessed: New Guidelines for Patients with Stable Coronary Disease?

0:00

HARVEY WHITE, Auckland City Hospital REFERENCE: ACC 2007 & N Engl J Med 356: March 2007 The finding from the COURAGE trial: that angioplasty adds no benefits to optimal medical therapy alone for

Harvey White

HARVEY WHITE, Auckland City Hospital

REFERENCE: ACC 2007 & N Engl J Med356: March 2007The finding from the COURAGE trial: that angioplasty adds no benefits to optimal medical therapy alone for patients with stable coronary disease, should give pause for thought among clinicians all over the world, according toHarvey White, who discussed the new data with Peter Goodwin.

Related Episodes

LDL-How Low?

LDL-How Low?

Terje Pedersen Terje Pedersen, Ulleval University, Oslo Eugene Braunwald, Harvard University, Boston Lowering LDL Cholesterol intensively as a means of treating aortic stenosis was found to have no be

4 September 2008
0:00
More about LDL-How Low?
Bivalirudin For Angioplasty: Expensive Heparin?

Bivalirudin For Angioplasty: Expensive Heparin?

Tony Gershlick Tony Gershlick, University of Leicester Adnan Kastrati, Deutsches Herzzentrum, Munich Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing deat

Remove Thrombus Before Primary Angioplasty!

Remove Thrombus Before Primary Angioplasty!

Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,